Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03706235 · ClinicalTrials.gov registry record
Colvera for Detection of Disease Recurrence
A clinical trial of Colorectal Adenocarcinoma, sponsored by Clinical Genomics Pathology.
- Completed
- Registry status
- 488
- Enrollment target
- 12
- Study locations
NCT03706235 is a study of Colorectal Adenocarcinoma that has completed, run by Clinical Genomics Pathology. The registered enrollment target is 488 participants, above the 293-participant average among 19 other Colorectal Adenocarcinoma trials with a reported enrollment target (67% higher). The trial reports 12 study locations across 11 states.
The verdict
NCT03706235, a study of Colorectal Adenocarcinoma, has completed, sponsored by Clinical Genomics Pathology.
- COMPLETED
- Registry status
- 488 participants
- Enrollment target
- 12
- Study locations
Study Summary
To compare the sensitivity and specificity estimates of Colvera with that of a commercially available CEA test for detection of recurrent disease in CRC subjects who are undergoing surveillance for recurrence.
Conditions Studied
Interventions
- OTHER Blood draw (venipuncture)
Study Locations (12)
Illinois
- Rush University Medical Center - Chicago
- NorthShore Health System - Evanston
California
- Torrance Memorial Physician Network - Redondo Beach
Delaware
- Bayhealth - Dover
Indiana
- Indiana University - Indianapolis
Louisiana
- Colon and Rectal Surgery Associates - Metairie
Michigan
- Providence Hospital-Ascension Health - Novi
Minnesota
- Virginia Piper Cancer Institute-Allina Health - Minneapolis
New Jersey
- Essex Oncology - Belleville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2020-04-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03706235
The ClinicalTrials.gov registry entry for NCT03706235 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 488 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 293-participant average among 19 other Colorectal Adenocarcinoma trials with a reported enrollment target (67% higher). The listed sponsor is Clinical Genomics Pathology, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Adenocarcinoma appearing as the primary indexed condition, and to 1 intervention - of which Blood draw (venipuncture) is the first listed.
NCT03706235 reports 12 study locations spanning 11 distinct geographic areas - top geographies include Illinois, California, Delaware.
Frequently Asked Questions
What is clinical trial NCT03706235 about?
NCT03706235 is a clinical study titled "Colvera for Detection of Disease Recurrence". To compare the sensitivity and specificity estimates of Colvera with that of a commercially available CEA test for detection of recurrent disease in CRC subjects who are undergoing surveillance for recurrence.
What is the current status of trial NCT03706235?
This trial is currently completed. The enrollment target is 488 participants. The study started on 2018-02-01. Estimated completion is 2020-04-29.
What conditions does trial NCT03706235 study?
This clinical trial studies the following conditions: Colorectal Adenocarcinoma.
What interventions are being tested in trial NCT03706235?
The interventions under investigation include: Blood draw (venipuncture) (OTHER).
Who is sponsoring clinical trial NCT03706235?
This trial is sponsored by Clinical Genomics Pathology, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03706235 being conducted?
This trial has 12 study locations across California, Delaware, Illinois, Indiana, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RECRUITING · Phase 1
-
Early Onset Colorectal Cancer Detection
RECRUITING
-
Stage II/III Colorectal Cancer Recurrence
RECRUITING
-
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
RECRUITING · Phase 1
-
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RECRUITING · Phase 1
-
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.